Purpose To assess changes in apparent diffusion coefficient (ADC) and fractional anisotropy (FA) values in brainstem gliomas (BSG) in children and to observe the temporal evolution of changes in the white matter tracts following therapy using diffusion tensor imaging (DTI) analysis. Methods Serial ADC and FA measurements were obtained in three patients with newly diagnosed BSG on two approved treatment protocols. Values were compared with a set of normative ADC, FA, and eigenvalues of agematched children of the corticospinal, transverse pontine and medial lemniscal tracts. Fiber tracking of the tracts coursing through the brainstem was performed using standard diffusion tractography analysis. Results We found increased ADC values within tumor at baseline compared to age-matched controls, with subsequent drop following treatment and subsequent increase with recurrence. Correspondingly, FA values were reduced at presentation, but transiently recovered during the phase of tumor response to treatment, and finally decreased significantly during tumor progression. These changes were concordant with the tractography analysis of white matter tracts in the brainstem. Based on these results, we suggest that initial changes in ADC and FA values reflects tract infiltration by tumor, but not complete disruption, whereas tumor progression results in complete loss of anisotropy possibly due to tract disruption.
Introduction
Diffuse intrinsic brainstem gliomas (BSG) in children are a group of malignant tumors with a poor prognosis [1, 2] . These tumors are usually fibrillary astrocytomas (WHO grade II) or malignant WHO grade III or IV astrocytomas at diagnosis. Treatment of BSG usually entails radiation therapy followed by or accompanied with chemotherapy, although outcomes after treatment are often poor [2, 3] . In addition to being the mainstay for diagnosis, conventional MR imaging has been used to monitor tumor response following therapy [4] .
Diffusion tensor imaging (DTI) is a technique that detects anisotropic diffusion, thereby enabling delineation of the major fiber tracts in the brainstem [5] . Assessment of precise tract location and tumor effect (tract displacement or apparent interruption due to tumor invasion) are possible using DTI. Prior studies have studied the role of DTI in supratentorial tumors and shown the value of measuring apparent diffusion coefficient (ADC) and fractional anisotropy (FA) to characterize tumors and assess peritumoral involvement of white matter tracts [6] [7] [8] . Invasion of the key tracts in the brainstem by pontine tumors has also been analyzed using DTI data, and these studies have shown reduced FA and elevated ADC values [9, 10] .
The purpose of our study was to assess the ADC and FA values in BSG and observe the temporal evolution of changes in the white matter tracts following therapy. Patients were serially assessed over time which is unique in this study group. We hypothesized that tractography would enable us to examine the level of recovery in tract anisotropy and help assess the response to therapy.
Materials and methods
This report describes findings in three patients with newly diagnosed BSG from a single institution treated on two Institutional Review Board-approved Pediatric Brain Tumor Consortium protocols. All patients gave their informed consent prior to inclusion in the studies. All three patients had undergone DTI performed prior to initiation of therapy and at least four time points after the initiation of therapy. The first treatment protocol (PBTC-007) was a phase II trial of gefitinib (Iressa®, AstraZeneca, Wilmington, DE; 250 mg/m 2 once daily) administered concurrently with irradiation. The second protocol (PBTC-014) was a phase II trial of tipifarnib (Zarnestra®, Johnson and Johnson Pharmaceutical Research and Development, Raritan, NJ; 125 mg/m 2 per dose twice daily) with concurrent irradiation. DTI was acquired in conjunction with other standard magnetic resonance imaging (MRI) sequences (T2, FLAIR and T1 with gadolinium) serially at protocol-specified time intervals (every 8 weeks during year 1, every 12 weeks thereafter, and at completion of therapy). Each course in both PBTC-007 and PBTC-014 was defined as 4 weeks.
MRI Technique
MRI of the brain was performed at 1.5 T on a GE scanner (GE Medical Systems, Signa Excite, Waukesha, WI) using a standard head coil. Conventional imaging 
Image analysis
Using the Vitrea® workstation (Vital Images, Minnetonka, MN), we performed volumetric tumor analyses on axial FLAIR sequences, and post-gadolinium axial T1 images with user-assisted semiautomated software; and then recorded tumor volumes on FLAIR and enhancement and cyst/necrosis on T1 gadolinium images [11] . Postprocessing of the DTI was performed using in house software written in IDL (ITT Visual Information Solutions™, Boulder, CO). FA, ADC, and the three eigenvector maps were generated for each series. FA color maps, colorcoded based on the direction of the principal eigenvector, were also generated. The major white matter tracts running through the brainstem were located on each FA color map using visual inspection and reference to a white matter atlas. Regions of interest (ROIs) were drawn within the left/ right corticospinal tracts, the left and right sides of the anterior transverse pontine fibers, the left and right sides of the posterior transverse pontine fibers, and the left/right medial lemnisci. If the tract could not be reliably identified, an ROI was placed in the approximate location of the tract in the brainstem. If the approximate location of the tract showed only necrosis, no ROI was chosen. These ROIs were then used to obtain the ADC, FA, and individual eigenvalues through the left and right side of each tract, and the average of the left and right FA graphed for each structure.
DTI data from age-matched controls were also obtained from the current NIH MRI database of normal brain development [12] . ADC, FA, and eigenvalues were extrapolated from DTI data of these controls and used to identify a baseline of normal values through the corticospinal, transverse pontine and medial lemniscal tracts of agematched children.
Fiber tractography was performed based on the fiber assignment by continuous tracking (FACT) algorithm and used to visualize the corticospinal tracts passing through the length of the brainstem. Superiorly, the corticospinal tract was visualized as far as practicable above the level of the corpus callosum. Using the Diffusion Toolkit and TrackVis software (Ruopeng Wang, Van J. Wedeen, TrackVis.org, Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Boston, MA), fibers were tracked with an angle threshold of 35°, FA threshold 0.2, and length threshold 10 mm. Attention was given to changes in the degree of disruption and displacement of the corticospinal tracts with reduction in size of tumor and tumor recurrence. MRI at presentation showed a T2 hyperintense pontine lesion on FLAIR images extending inferiorly into the upper medulla, posteriorly into the middle cerebellar peduncles and superiorly into the midbrain (Fig. 1a) . Treatment was instituted on protocol PBTC 007 including radiation and concurrent gefitinib. Subsequent imaging performed after completion of radiotherapy showed decrease in tumor size (Fig. 1b) . Imaging performed 14 months after therapy showed progression of tumor, with increased size as seen on FLAIR images (Fig. 1c ) and increased enhancement(not shown).
Tractography performed at these three time points shows initial attenuation of the corticospinal and transverse pontine fibers at diagnosis (Fig. 2a) . In contrast, the scan performed after completion of radiotherapy demonstrated improved visualization of the tracts coursing through the brainstem (Fig. 2b) , with recovery of the FA (Fig. 3) and alignment in response to therapy, possibly as a result of reduction in edema within the tracts. Subsequently, tract visualization deteriorated (Fig. 2c) in conjunction with progression of the tumor.
Case 2
Patient 2 was a previously healthy 7-year-old who presented with a 2-week history of excessive blinking and squinting with subsequent progression to diplopia at the time of presentation to the hospital. MRI at presentation showed a nonenhancing lesion with T2 prolongation on FLAIR images (Fig. 4a) . Follow-up MRI performed at 8 weeks after presentation and institution of treatment on PBTC protocol 007 with gefitinib and concurrent radiation therapy showed decrease in size of the nonenhancing T2 prolongation within the pons compared to the prior study (Fig. 4b) . Clinical symptoms improved at this time. Imaging performed 7 months after therapy showed increased size of the tumor, indicating tumor progression (Fig. 4c) .
Tractography showed decreased visualization of the corticospinal and transverse pontine fibers at diagnosis (Fig. 5a ). Scan performed following completion of radiotherapy demonstrated improved visualization of the tracts coursing through the brainstem (Fig. 5b) , with recovery of the FA (Fig. 6 ) and alignment in response to therapy. Subsequently, tracts in the brainstem were attenuated in conjunction with progression of the tumor (Fig. 5c ).
Case 3
Patient 3 was a previously healthy 4-year-old boy who presented with a 4-day history of unsteady gait and ataxia, with more acute facial nerve palsy. An MRI performed at presentation demonstrated a T2 hyperintense mass in the pons (Fig. 7a) with an enhancing central component and three smaller nodular areas of enhancement on the right side of the lesion (not shown). Treatment was instituted on protocol PBTC 014 using tipifarnib and radiation therapy. After an initial decrease in size of the tumor (Fig. 7b) , there was tumor progression with central necrosis 7 months after treatment (Fig. 7c ).
Tractography at presentation (Fig. 8a ) demonstrated posterior displacement of medial lemnisci and anterior transverse pontine fibers and infiltration of the corticospinal tracts and posterior transverse pontine fibers. Subsequent imaging performed showed slightly improved visualization of the long tracts in the brainstem (Fig. 8b ) soon after completion of radiotherapy. At the time of tumor progression, tract visualization in the brainstem was poor (Fig. 8c) , indicating that the tracts were severely compromised, and individual tracts could not be identified on the color FA maps. Due to these limitations, calculation of exact ADC values within the tumor was not considered diagnostic in this case.
Tumor volume versus time
After radiation, there was decrease in tumor volume in all patients. At the time of progression of tumor there was increased tumor volume. Enhancement at baseline was present in two of the three patients with mean gadolinium enhancing volume of 1.81 cm 3 (range 0.63-2.99 cm 3 ). The ADC values for the corticospinal tracts were compared to age-matched controls (AMC) in each case, and the results are shown in the graph (Fig. 9) . In all cases, there was increase in ADC values within the tumor at baseline compared to age-matched controls.
Discussion
This study followed BSG using serial DTI before therapy, during and after radiation therapy and drug therapy. BSGs have a number of features that preclude resection including their infiltration of the rich white matter network in the brainstem, which is quite often engulfed, displaced, or destroyed by tumor growth [1, 13] .
Our preliminary study provides insight on how the white matter tracts are affected by tumor and subsequently by radiation and treatment. Conventional MR imaging has previously been used to follow treatment of diffuse brain stem gliomas. However, the white matter appears homogeneous on MR images and therefore, it is not possible to distinguish the precise relationship of tumor with the white matter tracts. The ability of DTI to detect anisotropic diffusion and allow the visualization of major fiber tracts in the brainstem may provide information about tumor involvement of the white matter tracts. A recent study with a small number of cases has suggested the utility of tractography in differentiating between BSG and demyelination with tract displacement seen more often in BSG and truncated fibers seen with demyelination [14] .
Prior studies have used quantitative DTI to explore the differences between the involvement of the corticospinal, transverse pontine and medial lemniscal tracts in patients with diffuse pontine gliomas and those with focal brainstem tumors [9, 15, 16] . Our report extends these observations in the more common diffusely infiltrating pontine gliomas by exploring the changes in the ADC and FA in these tracts associated with treatment response and subsequent disease progression.
Our cases showed diffuse infiltration of the corticospinal and transverse pontine tracts at presentation and displacement of the individual corticospinal tracts and posterior displacement of the medial lemnisci. As shown by other This finding may also help us understand the exact nature of white matter involvement by tumor in these patients. Prior reviews have discussed the altered states of white matter that result from neoplastic involvement, which may affect the measurement of diffusion tensor anisotropy and orientation, influencing patterns on directional DTI color maps [13, 17] . The possible mechanisms suggested include: (1) bulk displacement of intact white matter tracts by tumor (identifiable in their new location or orientation on directional DTI color maps with preserved anisotropy); (2) edema within preserved tracts (with some loss of some anisotropy but retention of enough directional organization to remain identifiable on directional DTI maps); (3) disruption of the directional organization of fiber tracts by infiltrating tumor, resulting in markedly altered color patterns on directional maps (causing substantially decreased anisotropy); and (4) complete tract disruption leading to isotropic diffusion resulting from loss of directional organization and diffusion anisotropy [13] . A combined mechanism with a mixture of edema and tumor invasion has also been proposed. Based on our results, the transient recovery suggests that the drop in FA at presentation reflects tract infiltration by tumor, but not Another finding that warrants highlighting is that the ADC was increased compared to normal age-matched controls and the FA decreased within the white matter tracts for all tumors before therapy. After radiation therapy, the ADC dropped and progressively increased with recurrence. This finding has been reported in a recent study in a similar group of patients [18] . Unique in this case series is the use of diffusion tractography on serial imaging studies during treatment which has, to our knowledge, not been reported in this patient population.
It is also noteworthy that although the three patients were on two different treatment protocols, the basis for both protocols used was a combination of radiotherapy and a chemotherapeutic agent affecting the Ras signal transduction cascade [19] . Therefore, the change in the ADC and FA values in the three cases is less likely to have been affected by differences in treatment methods.
Based on the results of this study, we are currently working on a larger prospective study of patients with BSG to explore DTI at diagnosis and early after irradiation as a response measure in these tumors. It may be important to determine in future studies whether there is a correlation between decreased FA values and severity of neurologic deficits, and if there is a threshold below which decreased FA values become clinically apparent.
Conclusion
DTI may have a role in assessing response of diffuse BSG to therapy. Serial imaging with DTI may be a more sensitive indicator of tumor response and may correlate better with response compared to conventional imaging. Larger prospective studies are required to investigate this matter further.
